ELLIPSE A/S: Financial statements 2022
CVR: 20560673
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ELLIPSE A/S (CVR 20560673) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -421,337 and a net result of DKK 1,121,861 compared with DKK 9,050,327 the year before. Equity in the 2022 report amounted to DKK 64,694,360. The solvency ratio was 94.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -421,337
- Profit/Loss
- DKK 1,121,861
- Equity
- DKK 64,694,360
- Total Assets
- DKK 68,410,362
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -421K | 1.1M | 64.7M | 1 |
| 2021 | - | 6.1M | 9.1M | 63.6M | 2 |
| 2020 | - | 12.9M | 3.9M | 148.5M | 35 |
| 2019 | - | 115.9M | 105.4M | 144.6M | 30 |
| 2018 | - | 43.9M | -117K | 39.1M | 35 |
Official annual report
Keep an eye on ELLIPSE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ELLIPSE A/S has published its annual report for 2021. Gross profit came to DKK 6,066,727, and the net result was DKK 9,050,327.
About ELLIPSE A/S
ELLIPSE A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 1997. The company has been dissolved on 30 April 2025. The company was registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company was previously named 3D - DANISH DERMATOLOGIC DEVELOPMENT A/S. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK 1,300,672 and a net result of DKK -24,466,572 compared with DKK 1,121,861 the year before. Equity in the 2023 report amounted to DKK 40,227,789.